Renaissance Technologies - BIO BLAST PHARMA LTD ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of BIO BLAST PHARMA LTD
ValueSharesWeighting
Q2 2017$139,000
+14.9%
207,700
+30.4%
0.00%
Q1 2017$121,000
-2.4%
159,300
+34.0%
0.00%
Q4 2016$124,000
-15.1%
118,900
+41.0%
0.00%
Q3 2016$146,000
+274.4%
84,300
+249.8%
0.00%
Q2 2016$39,00024,1000.00%
Other shareholders
BIO BLAST PHARMA LTD shareholders Q3 2017
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 206,054$214,0000.38%
Anson Funds Management LP 270,793$282,0000.09%
SABBY MANAGEMENT, LLC 660,157$687,0000.04%
OPPENHEIMER & CO INC 24,700$26,0000.00%
UBS Group AG 4,066$4,0000.00%
BlackRock Investment Management, LLC 1,255$1,0000.00%
Virtu KCG Holdings LLC 15,032$16,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 1,000$1,0000.00%
BlackRock Fund Advisors 16,786$17,0000.00%
MORGAN STANLEY 1,026$2,0000.00%
View complete list of BIO BLAST PHARMA LTD shareholders